← Eichor
Condition: Facioscapulohumeral Muscular Dystrophy Type 1 Fshd1 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Facioscapulohumeral Muscular Dystrophy Type 1 Fshd1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
Phase 3 · 46 location(s) · Avidity Biosciences, Inc. · NCT07038200A Registered Cohort Study on FSHD1
Phase N/A · 1 location(s) · Ning Wang, MD., PhD. · NCT04369209
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.